Westlake BioPartners GP I, LLC
CIK 2007650 · last filed 2025-12-22
Westlake BioPartners GP I, LLC is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing shows the insider bought $4.0M of KYTX on Dec 22, 2025. Across all open-market trades the lifetime net is +$4.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $30.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$30.30M
1
1
$4.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KYTX | 10%+ Owner | 3,787,940 | $8.00 | $30.30M | $4.00M | 1 | 2025-12-22 |
Recent Filings
1 filingNotice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.